Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · IEX Real-Time Price · USD
6.35
-0.09 (-1.40%)
May 2, 2024, 4:30 PM EDT - Market closed
Lifecore Biomedical Balance Sheet
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 19.09 | 0.99 | 1.16 | 0.36 | 1.08 | 2.9 | 6 | 9.89 | 14.13 | 14.24 | Upgrade
|
| Cash & Cash Equivalents | 19.09 | 0.99 | 1.16 | 0.36 | 1.08 | 2.9 | 6 | 9.89 | 14.13 | 14.24 | Upgrade
|
| Cash Growth | 1826.44% | -14.50% | 221.94% | -66.67% | -62.75% | -51.67% | -39.38% | -29.96% | -0.81% | -6.68% | Upgrade
|
| Receivables | 29.02 | 38.31 | 41.43 | 76.21 | 69.57 | 53.88 | 45.9 | 46.41 | 46.48 | 44.73 | Upgrade
|
| Inventory | 40.84 | 36 | 63.08 | 66.31 | 54.13 | 31.82 | 23.62 | 25.54 | 25.03 | 24.74 | Upgrade
|
| Other Current Assets | 4.92 | 41.36 | 42.66 | 14.23 | 8.26 | 8.47 | 5.76 | 4.47 | 7.57 | 7.23 | Upgrade
|
| Total Current Assets | 93.88 | 116.67 | 148.32 | 157.11 | 133.04 | 97.06 | 81.28 | 86.3 | 93.2 | 90.93 | Upgrade
|
| Property, Plant & Equipment | 138.67 | 124.22 | 137.38 | 217.66 | 200.03 | 159.62 | 133.22 | 120.88 | 84.47 | 74.14 | Upgrade
|
| Long-Term Investments | 0 | 0 | 0 | 56.9 | 61.1 | 66.5 | 63.6 | 62.7 | 61.5 | 40.39 | Upgrade
|
| Goodwill and Intangibles | 18.08 | 18.08 | 59.55 | 107.49 | 121.99 | 76.35 | 77.32 | 71.02 | 105.88 | 106.77 | Upgrade
|
| Other Long-Term Assets | 2.92 | 15.73 | 157.67 | 2.16 | 2.93 | 5.16 | 3.19 | 1.75 | 1.42 | 1.39 | Upgrade
|
| Total Long-Term Assets | 159.67 | 158.04 | 354.6 | 384.21 | 386.05 | 307.64 | 277.33 | 256.35 | 253.26 | 222.69 | Upgrade
|
| Total Assets | 253.55 | 274.7 | 502.92 | 541.31 | 519.09 | 404.7 | 358.61 | 342.65 | 346.47 | 313.62 | Upgrade
|
| Accounts Payable | 22.1 | 12.95 | 16.3 | 51.65 | 53.97 | 34.67 | 24.53 | 30.9 | 35.01 | 32.12 | Upgrade
|
| Deferred Revenue | 4.06 | 0.92 | 0.64 | 0.35 | 0.5 | 2.63 | 0.31 | 0.83 | 0.84 | 1.25 | Upgrade
|
| Current Debt | 1.85 | 142.55 | 30.6 | 93.38 | 61.87 | 31.94 | 7.94 | 11.37 | 8.35 | 6.06 | Upgrade
|
| Other Current Liabilities | 11.29 | 20.16 | 54.35 | 19.01 | 20.75 | 19.14 | 18.68 | 13.23 | 11.95 | 8.97 | Upgrade
|
| Total Current Liabilities | 39.29 | 176.58 | 101.89 | 164.39 | 137.09 | 88.38 | 51.45 | 56.34 | 56.16 | 48.39 | Upgrade
|
| Long-Term Debt | 110.77 | 7.66 | 185.26 | 127.74 | 90.73 | 41 | 46.03 | 49.78 | 34.17 | 28.32 | Upgrade
|
| Other Long-Term Liabilities | 68.39 | 2.64 | 12.99 | 18.14 | 21.13 | 22.77 | 32.97 | 24.19 | 36.03 | 32.15 | Upgrade
|
| Total Long-Term Liabilities | 179.17 | 10.3 | 198.25 | 145.88 | 111.86 | 63.77 | 79 | 73.96 | 70.2 | 60.47 | Upgrade
|
| Total Liabilities | 218.46 | 186.88 | 300.14 | 310.27 | 248.95 | 152.14 | 130.46 | 130.3 | 126.36 | 108.86 | Upgrade
|
| Total Debt | 112.62 | 150.2 | 215.86 | 221.12 | 152.59 | 72.94 | 53.97 | 61.15 | 42.52 | 34.37 | Upgrade
|
| Debt Growth | -25.02% | -30.42% | -2.38% | 44.91% | 109.20% | 35.15% | -11.74% | 43.82% | 23.70% | -22.42% | Upgrade
|
| Retained Earnings | -178.54 | -78.97 | 38.58 | 71.25 | 109.71 | 109.3 | 84.47 | 73.46 | 85.1 | 71.55 | Upgrade
|
| Comprehensive Income | 0 | -0.59 | -1.36 | -2.81 | 0.06 | 1.15 | 0.43 | 0 | 0 | 0 | Upgrade
|
| Shareholders' Equity | -4.23 | 87.82 | 202.78 | 231.04 | 270.14 | 252.56 | 226.61 | 210.73 | 218.43 | 203.07 | Upgrade
|
| Net Cash / Debt | -93.53 | -149.21 | -214.7 | -220.76 | -151.51 | -70.04 | -47.97 | -51.26 | -28.39 | -20.13 | Upgrade
|
| Net Cash Per Share | -3.12 | -5.06 | -7.33 | -7.57 | -5.30 | -2.51 | -1.73 | -1.90 | -1.04 | -0.74 | Upgrade
|
| Working Capital | 54.59 | -59.91 | 46.43 | -7.28 | -4.05 | 8.69 | 29.83 | 29.96 | 37.04 | 42.54 | Upgrade
|
| Book Value Per Share | -0.14 | 2.98 | 6.92 | 7.92 | 9.53 | 9.17 | 8.31 | 7.79 | 8.13 | 7.63 | Upgrade
|